Here, the experts at Gnosis by Lesaffre explain the benefits of Quatreflora yeast solution vs bacteria in a handy diagram
Infographic tool to settle the differences and features of Quatreflora
The vaginal balance is fragile and can be disrupted in response to internal and external stresses such as hormonal variations, drug exposure like antibiotics treatment as well as environmental factors such as contraception and even menstruation.
As many as 75% of women will experience a vaginal infection in their lifetime, with more than 372 million women affected by recurrent vulvovaginal candidiasis during their lifetime.
Vaginal dysbiosis is an extremely debilitating condition, causing a range of symptoms that can have siginificant consequences on a woman’s life (health, sexuality, quality of life and self-confidence) - especially since high rates of resistance and recurrence can occur after pharmaceutical treatment with antimicrobial agents. Therefore treatment can cause some frustration and anxiety.
There is a demand in the market for preventing and restoring the imbalance of the vaginal microbiota. Probiotic treatments have been considered important to protect and avoid the disruption of the vaginal microbiome, helping to prevent infections and discomfort that can occur afterwards.
However, the awareness of yeast probiotic benefits and the main differences with bacterial probiotics are not well known. Regulation and balancing of intimate microbiome is often weakened during infections.
Quatreflora, the brand of a clinically proven yeast solution for vaginal health, is obtained from the patented yeast Saccharomyces cerevisiae CNCM I-3856, proprietary of Gnosis by Lesaffre, and is an ally for intimate wellbeing.
Quatreflora contributes to restoring the normal vaginal flora with several mechanisms during antibiotic treatment, helping to improve functionality and physiological state, limiting the probability of new external aggressions, especially by yeasts such as Candida albicans.
The efficacy and the mechanism of action have been clinically tested, with proven migration of the yeast Saccharomyces cerevisiae CNCM I-3856 -Quatreflora- from the rectum to the vagina that has never been described effective after just four weeks of oral supplementation.
The main differences between Quatreflora and the probiotic bacteria have been easily described in an infographic, reporting all the clinical references and studies supporting the ingredient and helping women's health.